I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...
Ozempic doesn't just reduce weight. Research shows GLP-1s also changes how much people spend on food, and the types of food ...
Ozempic and Wegovy have become popular options for people looking to lose weight, but there are some risks and side effects ...
Hims & Hers Health (NYSE: HIMS) is coming off a fantastic year in 2024 when its share price skyrocketed 172%. Is Hims & Hers ...
Until two years ago, such discussion was of little practical relevance, since there were few treatments for obesity between ...
GoodRx CEO Wendy Barnes outlined the company's priorities at the 2025 JP Morgan Healthcare Conference in San Francisco.
The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...
Proponents of Ozempic microdosing claim you'll reap the drug's benefits with fewer side effects. But is taking small doses of GLP-1 agonists safe and effective for weight loss?
Shares of several obesity drugmakers dip after LLY lowered its revenue outlook for 2024 amid slower-than-expected sales ...
Leicester is the weight loss injection capital with almost 2,000 drugs prescribed each month, 6.8 times the proportion dished ...
Dr Daniel Rosen, who is a surgeon and obesity medicine specialist based out of New York, says a 'legitimate number' of his ...
A new generation of weight loss drugs has helped some people lose significant amounts of weight and improve their health.